Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy
Increased copy number alterations, indicative of chromosomal instability, is associated with poor cancer outcome. Here, metastatic colorectal cancer patients displaying intermediate-high CIN associate with improved outcome following chemotherapy and bevacizumab treatment, suggesting CIN as a predict...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
05 October 2018
|
| In: |
Nature Communications
Year: 2018, Volume: 9, Pages: 1-16 |
| ISSN: | 2041-1723 |
| DOI: | 10.1038/s41467-018-06567-6 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1038/s41467-018-06567-6 Verlag, Volltext: https://www.nature.com/articles/s41467-018-06567-6 |
| Author Notes: | Dominiek Smeets et al. |
| Summary: | Increased copy number alterations, indicative of chromosomal instability, is associated with poor cancer outcome. Here, metastatic colorectal cancer patients displaying intermediate-high CIN associate with improved outcome following chemotherapy and bevacizumab treatment, suggesting CIN as a predictive biomarker. |
|---|---|
| Item Description: | Gesehen am 13.12.2019 |
| Physical Description: | Online Resource |
| ISSN: | 2041-1723 |
| DOI: | 10.1038/s41467-018-06567-6 |